U.S. federal trademark · Serial No. 90455526 · Reg. No. 6817322
Cancer health care management utilizing targeted tumor sequencing tests to detect gene mutations and aberrations in rare and common cancers to foster development of individualized treatment options for patients
compiling medical data for research purposes in the field of gene mutations in rare and common cancers for evaluation and assessing tumor biology, prognosis, and treatment and patient drug response
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.